TP53 and cancer: In accordance with previously published data [10,13], PANC-1 and MDA-MB-231 cancer cells bearing mutant p53 proteins showed less sensitivity to GEM treatment with respect to MCF-7 cancer cells and their viability was reduced between 15–30% after 72 h of incubation (Figure S13A,B).